Case Study: Weight Loss in a Patient with Type 2 Diabetes: Challenges of Diabetes Management

被引：5

作者：

Lotfi, Katayoun ^{[1
]}

Palmer, Kenya ^{[2
]}

Apovian, Caroline M. ^{[3
]}

机构：

[1] Boston Med Ctr, Ctr Nutr & Weight Management, Boston, MA USA

[2] Boston Med Ctr, Endocrinol Diabet Nutr & Weight Management, Boston, MA USA

[3] Boston Univ, Sch Med, Nutr & Weight Management Ctr, Obes Res Ctr,Boston Med Ctr, Boston, MA 02118 USA

来源：

OBESITY | 2015年 / 23卷

关键词：

D O I：

10.1002/oby.21095

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This patient with BMI 36 kg/m2 and T2DM on insulin glargine and glyburide as well as atenolol for HTN was able to lose 10% of his initial body weight with a low-carbohydrate diet and exercise and adjustment of medications in approximately a 36-week time frame. Insulin glargine and glyburide were reduced gradually with blood glucose monitoring and replaced by an increase in metformin, start of liraglutide, and eventually phentermine/topiramate and canagliflozin (Figure). Therefore, medications that can exacerbate weight gain were discontinued in place of medications which promote weight loss (1). © 2015 The Obesity Society.

引用

页码：S11 / S12

页数：3

共 1 条

[1] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS' COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2013 CONSENSUS STATEMENT - EXECUTIVE SUMMARY [J].

Garber, Alan J. ;

Abrahamson, Martin J. ;

Barzilay, Joshua I. ;

Blonde, Lawrence ;

Bloomgarden, Zachary T. ;

Bush, Michael A. ;

Dagogo-Jack, Samuel ;

Davidson, Michael B. ;

Einhorn, Daniel ;

Garvey, W. Timothy ;

Grunberger, George ;

Handelsman, Yehuda ;

Hirsch, Irl B. ;

Jellinger, Paul S. ;

McGill, Janet B. ;

Mechanick, Jeffrey I. ;

Rosenblit, Paul D. ;

Umpierrez, Guillermo E. ;

Davidson, Michael H. .

ENDOCRINE PRACTICE, 2013, 19 (03) :536-547

← 1 →